Achondroplasia Market Size, Epidemiology, Treatment, Drugs Pipeline, Market Analysis and Companies by DelveInsight

Achondroplasia Treatment Market

Achondroplasia is the most common of skeletal dysplasia that results in marked short stature (dwarfism). It is a human bone genetic disorder of the growth plate and is the most common form of inherited disproportionate short stature.


DelveInsight’s “Achondroplasia Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some facts of Achondroplasia Market Report are:

According to Columbia University Medical Center (CUMC), this disorder occurs in approximately 1 in 25,000 live births worldwide.
The prevelance rates have correlation to father’s age as mutations occur exclusively in the male and older men who have a higher probability of having an affected child than younger ones (Deepali N.shinde et al)
The population-based study conducted by DK.Waller et al in US, stated that the prevalence of de novo Achondroplasia has been significantly increased with age of father. The prevelance data varied according to father’s age such as 25–29, 30–34, 35–39, and ≥40 years, with reported rates of 2.8, 2.8, 4.9 and 5.0 respectively.
The prevalence of achondroplasia ranged from 0.36 to 0.60 per 10,000 livebirths
According to a study, the recurrence risk of Achondroplasia among siblings of an affected individual was found to be 0.23% (Mettler and Fraser)


Request for Sample Report:


Scope of the Achondroplasia Market Report

The report covers the descriptive overview of Achondroplasia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Achondroplasia epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Achondroplasia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Achondroplasia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Achondroplasia market


List of Achondroplasia Key Players involved in the report

Ascendis Pharma
And many others


Request for Sample Report:


Achondroplasia Market Report

The children affected by Achondroplasia are delayed in reaching gross motor milestones such as head control, and independent sitting and walking. There are some serious neurological problems that may also occur due to narrowing of the spinal canal and nerve compression.


Achondroplasia Market Insights

It is caused by one of two mutations (G1138A and G1138C) in the FGFR3 (Fibroblast Growth Factor Receptor 3) gene at chromosome locus 4p16.3. The mutations cause the FGFR3 protein to be overly active, which interferes with skeletal development and leads to disturbances in bone growth seen with this disorder.


Achondroplasia Therapies

TransCon CNP
Infigratinib (Bridgebio/Qued)
And Many others 



Achondroplasia Treatment Market

The current market is occupied with this symptomatic treatment and surgery only. To be effective, a new treatment approach must consider Achondroplasia is a complex disease, correcting the short stature and preventing complications. Understanding the pathophysiology of the disease is essential to achieve this and correcting the growth of all bones affected by the disease, will define the future treatment strategy.


Table of Content:

1. Key Insights

2. Executive Summary of Achondroplasia

3. Competitive Intelligence Analysis for Achondroplasia

4. Achondroplasia: Market Overview at a Glance

4.1. Achondroplasia Total Market Share (%) Distribution in 2018

4.2. Achondroplasia Total Market Share (%) Distribution in 2030

5. Achondroplasia: Disease Background and Overview

6. Patient Journey

7. Achondroplasia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Achondroplasia Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Achondroplasia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Achondroplasia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States